Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ke Luoxin capsule for nonproliferative diabetic retinopathy
CTR20131323Phase 2Completed
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Keluoxin in diabetic retinopathy (DR), sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Started Mar 2014; status: completed.
02
Drugs
Keluoxin
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on CTR20131323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131323.